Novel Antiaging Regenerative Skin Care Regimen Containing Human Platelet Extract (HPE)
NCT05457491 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 56
Last updated 2024-10-04
Summary
The Researchers are trying to study a cosmetic skin care product called human platelet extract (HPE) to see if it can be used as a possible treatment for skin anti-aging and skin rejuvenation. They are trying find out the safety and tolerability of topical HPE after multiple doses of topical administration
Conditions
- Skin Aging
Interventions
- BIOLOGICAL
-
Human platelet extract (cosmetic product)
A leukocyte depleted allogeneic product derived from human U.S. sourced pooled apheresed platelets (derived from screened healthy donors). Applied to face twice daily for 12 weeks.
- OTHER
-
Vanicream Gentle Facial Cleanser
A mild cleanser specifically formulated for daily facial use. Applied to face twice daily for 12 weeks
- OTHER
-
EltaMD UV Daily Broad-Spectrum SPF 40
A daily moisturizer with a lightweight formula that provides broad-spectrum sunscreen protection. EltaMD UV Daily Broad-Spectrum SPF 40 provides powerful protection against the sun's harmful UV rays, as it hydrates and is gentle enough for post-procedure skin. Powered by hyaluronic acid, this face sunscreen plumps the skin with lightweight moisture, while micronized zinc and octinoxate shield skin from UVA/UVB rays to prevent the visible signs of environmentally caused aging. Applied to face once daily for 12 weeks.
- OTHER
-
EltaMD PM Therapy Facial Moisturizer
A fortifying face moisturizer to repair elasticity and vitality. EltaMD PM Therapy Facial Moisturizer restores youthfulness while strengthening the skin's natural moisture barrier. Niacinamide blends with antioxidants to boost the skin color and tone, as it speeds up the skin's repair processes. Rice protein peptides aid in encouraging cell growth, promoting collagen formation and improving elasticity. Applied to face once daily for 12 weeks.
- OTHER
-
Vanicream Lite Lotion
Lotion to restore and maintain a normal moisture level. Applied to face twice daily for 12 weeks.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Saranya P Wyles, M.D., Ph.D. · Mayo Clinic
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-01
- Primary Completion
- 2022-07-07
- Completion
- 2022-07-07
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Topical Brimonidine to Reduce Inflammation After IPL-treatment in Patients With Facial Telangiectasias
NCT02761174 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
NCT06659640 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers
NCT01112787 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris
NCT03433378 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Persistent Facial Erythema
NCT01882712 ·Status: WITHDRAWN ·Phase: PHASE3
-
Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH)
NCT01038869 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate Efficacy and Tolerability of Two Topical Regimens in Subjects With Moderate to Severe Facial Photodamage Who Have Received Cosmetic Injections
NCT03559972 ·Status: COMPLETED ·Phase: NA
-
Topical 5% Tranexamic Acid as a Treatment for Postinflammatory Hyperpigmentation Due to Acne Vulgaris
NCT03361345 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
The Efficacy of the Alma Hybrid System for a New Approach of Facial Skin Treatment
NCT04640207 ·Status: COMPLETED ·Phase: NA
-
Open-label, Single-arm, Proof of Concept Study in Subjects with Mild-to-moderate Facial Hyperpigmentation
NCT06473974 ·Status: WITHDRAWN ·Phase: PHASE2
-
Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne
NCT00594425 ·Status: COMPLETED ·Phase: PHASE2
-
Platelet-rich Plasma With Topical Retinoids Versus Topical Retinoids Alone in Acne Vulgaris
NCT06281782 ·Status: RECRUITING ·Phase: NA
-
Split-face Study Comparing the Cosmetic Efficacy and Tolerability of Two Topical Products in Participants With Moderate Facial Melasma
NCT02977507 ·Status: COMPLETED ·Phase: NA
-
Trial of Methyl Aminolevulinate Plus Aktilite in Facial Photodamage
NCT00629317 ·Status: COMPLETED ·Phase: PHASE3
-
An 18-week Study to Evaluate a Test Product With a Marketed Prescription Product
NCT07136766 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne
NCT05704114 ·Status: COMPLETED ·Phase: PHASE4
-
Exploratory Study Evaluating the Effects of Dermo-cosmetic RV5026B Applied for 2 Months in Adults With Erythrocouperosis
NCT06824870 ·Status: TERMINATED ·Phase: NA
-
Clinical Study to Evaluate Alexandrite Laser for the Treatment of Acne Scars
NCT04807179 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris
NCT02100527 ·Status: WITHDRAWN ·Phase: PHASE2
-
Treatment of Dilated Blood Vessels on the Cheeks With a New Yellow Laser and a Traditional Green Laser
NCT03472859 ·Status: COMPLETED ·Phase: NA
-
Trial Evaluating Both Tolerability and Improvement for Signs of Facial Photoaging, Discoloration, and Texture in Adult Females of All Skin Types by Combining a Placebo Moisturizer and Non-ablative Laser.
NCT06090071 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne
NCT01017120 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema
NCT05300542 ·Status: COMPLETED ·Phase: NA
-
Trial of Single Microneedle Radiofrequency for Moderate-to-Severe Acne Vulgaris
NCT04213638 ·Status: UNKNOWN ·Phase: NA
-
Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States
NCT02867722 ·Status: WITHDRAWN ·Phase: NA